Switching to emicizumab: A prospective surveillance study in haemophilia A subjects with inhibitors

Haemophilia. 2023 Jan;29(1):348-351. doi: 10.1111/hae.14685. Epub 2022 Oct 31.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Bispecific* / pharmacology
  • Antibodies, Bispecific* / therapeutic use
  • Antibodies, Monoclonal, Humanized / pharmacology
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Factor VIII / therapeutic use
  • Hemophilia A* / drug therapy
  • Humans
  • Prospective Studies

Substances

  • emicizumab
  • Antibodies, Bispecific
  • Antibodies, Monoclonal, Humanized
  • Factor VIII